XML 11 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Beginning Balance, Values at Dec. 31, 2023 $ 250,556 $ 78 $ 823,029 $ (52) $ (572,499)
Beginning Balance, Shares at Dec. 31, 2023   78,369,099      
Exercise of stock options 217   217    
Exercise of stock options, Shares   105,526      
Issuance of common stock, net of issuance costs, Value 32,198 $ 7 32,191    
Issuance of common stock, net of issuance costs, Shares   6,639,348      
Exercise of pre-funded warrants, Value   $ 5 (5)    
Exercise of pre-funded warrants, Shares   5,243,400      
Restricted stock vested in the period   124,695      
Stock-based compensation 4,660   4,660    
Other comprehensive loss (50)     (50)  
Net loss (25,176)       (25,176)
Ending Balance, Values at Mar. 31, 2024 262,405 $ 90 860,092 (102) (597,675)
Ending Balance, Shares at Mar. 31, 2024   90,482,068      
Beginning Balance, Values at Dec. 31, 2024 293,105 $ 109 1,003,685 10 (710,699)
Beginning Balance, Shares at Dec. 31, 2024   109,381,556      
Exercise of stock options $ 62   62    
Exercise of stock options, Shares 43,113 43,113      
Restricted stock vested in the period   289,735      
Stock-based compensation $ 5,078   5,078    
Other comprehensive loss (101)     (101)  
Net loss (54,356)       (54,356)
Ending Balance, Values at Mar. 31, 2025 $ 243,788 $ 109 $ 1,008,825 $ (91) $ (765,055)
Ending Balance, Shares at Mar. 31, 2025   109,714,404